This company has been acquired
Change Healthcare Management
Management criteria checks 4/4
Key information
Neil de Crescenzo
Chief executive officer
US$9.3m
Total compensation
CEO salary percentage | 9.5% |
CEO tenure | 9.8yrs |
CEO ownership | 0.2% |
Management average tenure | 2.5yrs |
Board average tenure | 5.8yrs |
Recent management updates
Recent updates
UnitedHealth completes acquisition of Change Healthcare
Oct 03Change Healthcare jumps after judge denies DOJ request to block UnitedHealth deal
Sep 19Change Healthcare gains amid final arguments in DOJ case to block UnitedHealth deal
Sep 08Data misuse risk against UnitedHealth used by DoJ to scuttle Change Healthcare deal - Bloomberg
Aug 11Catalyst watch: Change Health/UNH DOJ court starts, PayPal earnings , unemployment data
Jul 29Change Healthcare: A Healthcare SaaS Opportunity At 11x Free Cash Flow
Feb 14Change Healthcare drops as DOJ sues to block Aon's planned $30B Willis Towers deal
Jun 17Change Healthcare EPS beats by $0.06, beats on revenue
May 26Change Healthcare Inc. 2021 Q3 - Results - Earnings Call Presentation
Feb 04UnitedHealth’s Change deal signals plans to expand Optum – Citi
Jan 06Change Healthcare Inc.: Solving Healthcare's Biggest Challenges
Dec 08Change Healthcare: Good Fundamentals At An Enticing Valuation
Dec 01Change Healthcare Inc. 2021 Q2 - Results - Earnings Call Presentation
Nov 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -US$77m |
Mar 31 2022 | US$9m | US$882k | -US$57m |
Dec 31 2021 | n/a | n/a | -US$78m |
Sep 30 2021 | n/a | n/a | -US$51m |
Jun 30 2021 | n/a | n/a | -US$57m |
Mar 31 2021 | US$10m | US$850k | -US$112m |
Dec 31 2020 | n/a | n/a | -US$966m |
Sep 30 2020 | n/a | n/a | -US$917m |
Jun 30 2020 | n/a | n/a | -US$969m |
Mar 31 2020 | US$10m | US$850k | -US$948m |
Dec 31 2019 | n/a | n/a | -US$84m |
Sep 30 2019 | n/a | n/a | -US$147m |
Jun 30 2019 | n/a | n/a | -US$72m |
Mar 31 2019 | US$2m | US$750k | -US$52m |
Dec 31 2018 | n/a | n/a | -US$70m |
Sep 30 2018 | n/a | n/a | US$71m |
Jun 30 2018 | n/a | n/a | US$67m |
Mar 31 2018 | US$8m | US$743k | US$61m |
Compensation vs Market: Neil's total compensation ($USD9.33M) is about average for companies of similar size in the US market ($USD8.53M).
Compensation vs Earnings: Neil's compensation has been consistent with company performance over the past year.
CEO
Neil de Crescenzo (61 yo)
9.8yrs
Tenure
US$9,329,762
Compensation
Mr. Neil E. de Crescenzo, IV serves as President and Chief Executive Officer at Change Healthcare, Inc. since 2013 and has been its Director since 2017. He has been the Chief Executive Officer and Presiden...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 9.8yrs | US$9.33m | 0.18% $ 16.3m | |
Executive VP & CFO | 4.6yrs | US$5.00m | 0.073% $ 6.6m | |
Executive Vice President of Enterprise Technology | 2.5yrs | US$2.73m | 0.027% $ 2.5m | |
Executive VP and President of Network Solutions | no data | US$3.14m | 0.066% $ 5.9m | |
Senior Advisor | less than a year | US$2.52m | 0.011% $ 1.0m | |
Executive VP and President of Sales & Operations | no data | US$2.65m | 0.021% $ 1.9m | |
Senior Director | no data | no data | no data | |
Executive VP & General Counsel | no data | no data | 0.016% $ 1.4m | |
Chief Compliance & Ethics Officer | 2.1yrs | no data | no data | |
Vice President of External Communications | 2.3yrs | no data | no data | |
Executive VP of Corporate Affairs & Chief Marketing Officer | no data | no data | 0.035% $ 3.1m | |
Senior Vice President of Corporate Development | 2.9yrs | no data | no data |
2.5yrs
Average Tenure
55.5yo
Average Age
Experienced Management: CHNG's management team is considered experienced (2.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 5.8yrs | US$9.33m | 0.18% $ 16.3m | |
Independent Director | 5.8yrs | no data | no data | |
Independent Director | 5.8yrs | US$315.20k | 0.029% $ 2.6m | |
Independent Director | 5.8yrs | US$300.20k | 0.010% $ 908.8k | |
Independent Chairman | 5.8yrs | US$465.20k | 0.067% $ 6.0m | |
Independent Director | 5.8yrs | US$315.20k | 0.010% $ 908.8k | |
Independent Director | 5.8yrs | US$285.20k | 0.0096% $ 869.1k | |
Independent Director | 3.2yrs | US$285.20k | 0.010% $ 908.8k | |
Independent Director | 3.3yrs | no data | no data | |
Independent Director | 2.4yrs | US$285.20k | 0.0066% $ 594.8k |
5.8yrs
Average Tenure
61yo
Average Age
Experienced Board: CHNG's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/10/03 11:04 |
End of Day Share Price | 2022/09/30 00:00 |
Earnings | 2022/06/30 |
Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Change Healthcare Inc. is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Matthew Gillmor | Baird |
Zhilin Long | Berenberg |
Steven Halper | Cantor Fitzgerald & Co. |